Equity Profile

PAHC

Phibro Animal Health Corporation

Health CarePharmaceuticals$1.3B

Aug26Wed

Pre-Earnings Brief

UpcomingQ4-2026After Close5:00 PM EDT

Company Snapshot

Phibro Animal Health Corporation (PAHC) operates in the health care sector, focusing on pharmaceuticals for animal health. The company plays a crucial role in the agricultural industry by providing products that enhance animal health and productivity, which is increasingly important as global food demand rises.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

$0.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PAHC Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+23.89%

Avg Stock Reaction

+0.37%

Last Quarter Recap

In Q3-2026, Phibro reported an EPS of $0.76, surpassing expectations by 5.85%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Phibro has consistently beaten EPS estimates in the past, but the lack of revenue guidance leaves uncertainty.

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or margin pressures could lead to a negative reaction, especially given the lack of management guidance.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.80

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand for its products.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products and managing costs, which is vital for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q4-2026?

Given Phibro's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock movement.

How is revenue growth trending in the current quarter?

Revenue trends will provide insight into the company's market position and demand for its products, which is critical for future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Phibro's ability to maintain its EPS growth trajectory despite potential revenue challenges, as historical performance shows a consistent ability to beat estimates.

Supporting Evidence

Phibro has a 100% EPS beat rate over the last eight quarters, indicating strong operational management.

The options market is pricing a significant move, suggesting that investors expect volatility that may not align with consensus expectations.

Key Risk

If EPS comes in below $0.70, it could undermine confidence in the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on maintaining strong EPS while addressing any revenue growth challenges.

Bull Confirmed If

An EPS of $0.80 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $0.70 would raise concerns about the company's profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±22.04%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±22.0% while PAHC has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

100.6%

Calls (100)P/C Ratio: 0.14Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Phibro beats expectations, history suggests a potential stock increase of around 0.37%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 2.28% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends and how they are impacting overall profitability.
2Management's commentary on operational efficiencies and cost management strategies.
3Insights into market demand for animal health products and any shifts in customer behavior.
4Any guidance on future quarters or changes in strategic direction.
5Details on competitive pressures and how Phibro plans to respond.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Sandisk Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

$0.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand for its products.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PAHC Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+23.89%

Avg Stock Reaction

+0.37%

Last Quarter Recap

In Q3-2026, Phibro reported an EPS of $0.76, surpassing expectations by 5.85%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as Phibro has consistently beaten EPS estimates in the past, but the lack of revenue guidance leaves uncertainty.

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or margin pressures could lead to a negative reaction, especially given the lack of management guidance.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.80

EPS is a key indicator of the company's profitability and overall financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand for its products.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products and managing costs, which is vital for profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q4-2026?

Given Phibro's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock movement.

How is revenue growth trending in the current quarter?

Revenue trends will provide insight into the company's market position and demand for its products, which is critical for future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Phibro's ability to maintain its EPS growth trajectory despite potential revenue challenges, as historical performance shows a consistent ability to beat estimates.

Supporting Evidence

Phibro has a 100% EPS beat rate over the last eight quarters, indicating strong operational management.

The options market is pricing a significant move, suggesting that investors expect volatility that may not align with consensus expectations.

Key Risk

If EPS comes in below $0.70, it could undermine confidence in the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on maintaining strong EPS while addressing any revenue growth challenges.

Bull Confirmed If

An EPS of $0.80 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $0.70 would raise concerns about the company's profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±22.04%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±22.0% while PAHC has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

100.6%

Calls (100)P/C Ratio: 0.14Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Phibro beats expectations, history suggests a potential stock increase of around 0.37%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 2.28% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth trends and how they are impacting overall profitability.
2Management's commentary on operational efficiencies and cost management strategies.
3Insights into market demand for animal health products and any shifts in customer behavior.
4Any guidance on future quarters or changes in strategic direction.
5Details on competitive pressures and how Phibro plans to respond.